Cite

HARVARD Citation

    Calvo, E. et al. (n.d.). 3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC). European journal of cancer. pp. S633-. [Online]. 
  
Back to record